Pelthos Therapeutics PTHS
NYSE PTHS
$21.35 +0.43 (+2.08%)
As of: Sep 30, 2026 · 10:00 AM EDT

Pelthos Therapeutics Inc. (PTHS) Total Debt (2022 - 2026)

Updated

Pelthos Therapeutics (PTHS) recorded Total Debt of $26.59 million in Q2 2026, compared with $131,868 a year earlier and up 0.9% from the prior quarter.

Analysis

Pelthos Therapeutics Inc. (PTHS) Total Debt (2022 - 2026) Analysis & Trends

At the end of FY2024, Pelthos Therapeutics reported Total Debt of $2.32 million, up 209.0% from FY2023.

  • Across earlier years, Total Debt came in at $750,082 in FY2023 (+615.7%) and $104,800 in FY2022.
  • The Q2 2026 figure is the highest quarterly Total Debt in data going back to Q4 2022.
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 26.59 Mn
Mar 31, 2026 26.36 Mn
Jun 30, 2025 131,868.00
Mar 31, 2025 131,868.00
Dec 31, 2024 2.32 Mn
Sep 30, 2024 131,868.00
Jun 30, 2024 131,868.00
Dec 31, 2023 750,082.00
Dec 31, 2022 104,800.00
API Access

Pelthos Therapeutics Inc. Total Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-debt&ticker=PTHS&period=max&api_key=YOUR_API_KEY